NCT05235009 - LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in Asymptomatic Adults (LEV87A) | Biotech Hunter

Enrollment

9,170

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Cancer

Interventions

DIAGNOSTIC_TEST

Combined free GAGome MCED test

The combined free GAGome MCED test aggregates measurements of plasma and urine GAGomes (the exhaustive human glycosaminoglycan profile) into a diagnostic score, the combined free GAGome MCED score. The measurements are performed using MIRAM MCED Kits (Elypta AB) and the scores are computed using Elypta SKY Software (Elypta AB)

Trial Locations (1)

Unknown

RECRUITING

Elypta AB, Stockholm